RenovaRP paracentesis management system decreases procedure time and improves patient experience new research shows

297
RenovaRP

Recently released clinical data has outlined the benefits of the RenovaRP paracentesis management system (GI Supply) for patients with ascites. The study, which was published in the Diagnostic and Interventional Radiology journal by Shane Weber (Dearborn, USA) et al, found that there was a substantially higher fluid flow rate during paracentesis using the RenovaRP system as compared to wall suction.1

The purpose of the study was to investigate if the use of RenovaRP as a treatment for ascites would reduce procedure time compared to standard wall suction without increasing adverse effects, such as hypotension or abdominal pain.2

Procedure room time decreased from 53 minutes with wall suction to 31 minutes with RenovaRP (p<0.001).3 The paper’s authors noted that the RenovaRP pump is portable, simple to use, requires little staff training, and can be used to perform paracentesis outside of interventional radiology. The authors also highlighted that, as a self-contained system, it avoids exposing medical team members to patients’ body fluids, which may occur during exchange of wall-suction canisters.4

Karen Brown (Salt Lake City, USA), a co-author of the research paper, said: “Exposure to a patient’s body fluids is a risk faced by healthcare professionals that must change cannisters or open cannisters to pour in the material that solidifies the removed fluid.”

Brown added that the patient experience “was comparable to conventional wall suction. Patients said they liked Renova better, which might have been due in part to it being a faster procedure”

The study authors also noted that on certain high-volume centres where paracentesis procedures are performed frequently, the RenovaRP pump can be expected to provide superior through-put with relatively minimal added procedural costs. In addition, the pump offers providers and patients substantially faster procedure times without adverse outcomes.5

Rhett Klein, vice president of sales and marketing at GI Supply, commented: “While we anticipated positive outcomes from this clinical study, our team was gratified that the results clearly support the benefits of the RenovaRP system. We are dedicated to enhancing patient safety and satisfaction in a cost-effective system that also supports the needs of medical staff.”

References: 

1: Weber S, Al-Dulaimi R, Quencer K, et al. Paracentesis: faster and easier using the RenovaRP® pump. Diagnostic and Interventional Radiology 2022
2: Ibid.


LEAVE A REPLY

Please enter your comment!
Please enter your name here